These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34344196)

  • 21. Non-eosinophilic corticosteroid unresponsive asthma.
    Pavord ID; Brightling CE; Woltmann G; Wardlaw AJ
    Lancet; 1999 Jun; 353(9171):2213-4. PubMed ID: 10392993
    [No Abstract]   [Full Text] [Related]  

  • 22. Budesonide + formoterol: new dose regimen. Asthma attacks: a step backwards.
    Prescrire Int; 2008 Apr; 17(94):57. PubMed ID: 18516807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Not Available].
    Reinhardt D
    MMW Fortschr Med; 2021 Apr; 163(8):27-28. PubMed ID: 33904080
    [No Abstract]   [Full Text] [Related]  

  • 24. Lost in the labyrinth of end points.
    Lipworth BJ
    Chest; 2001 Jul; 120(1):323-4. PubMed ID: 11451868
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma.
    Pelaia G; Vatrella A; Busceti MT; Fabiano F; Terracciano R; Matera MG; Maselli R
    Pulm Pharmacol Ther; 2016 Oct; 40():15-21. PubMed ID: 27381656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of budesonide inhalation suspension in children with asthma.
    West KM; Culhane NS
    Ann Pharmacother; 2002 Feb; 36(2):322-5. PubMed ID: 11847955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma.
    Tsai YG; Lee MY; Yang KD; Chu DM; Yuh YS; Hung CH
    J Pediatr; 2001 Sep; 139(3):433-7. PubMed ID: 11562625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical pharmacotherapy for pediatric asthma.
    Sherman J; Hendeles L
    Pediatr Ann; 2000 Dec; 29(12):768-73. PubMed ID: 11131944
    [No Abstract]   [Full Text] [Related]  

  • 29. [A lung image with cavitation].
    de Frutos Arribas JF; Pérez Paredes G; Alberte Castiñeira A; Carretero Sastre JL
    Rev Clin Esp; 2004 Oct; 204(10):551-3. PubMed ID: 15456612
    [No Abstract]   [Full Text] [Related]  

  • 30. Post hoc analysis and claims of superiority in the EXCEL trial.
    Naya IP; Andersson TL
    Respir Med; 2007 Mar; 101(3):681-2; author reply 683. PubMed ID: 17166708
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mild asthma: new therapeutic approaches].
    Dahan R
    Rev Pneumol Clin; 1998 Jan; 54 Suppl 1():S22-3. PubMed ID: 9769974
    [No Abstract]   [Full Text] [Related]  

  • 32. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma.
    Matthews EE; Curtis PD; McLain BI; Morris LS; Turbitt ML
    Acta Paediatr; 1999 Aug; 88(8):841-3. PubMed ID: 10503682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Budesonide-formoterol reliever therapy in intermittent
    Papi A; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Holliday M; Houghton C; Morandi L; Oldfield K; Pavord ID; Reddel HK; Williams M; Weatherall M; Beasley R;
    Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 33060151
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bronchial asthma. A new steroid acts fast and directly].
    MMW Fortschr Med; 2003 Dec; 145(49):59. PubMed ID: 14964000
    [No Abstract]   [Full Text] [Related]  

  • 35. Budesonide/formoterol in the treatment of asthma.
    Hodgson D; Mortimer K; Harrison T
    Expert Rev Respir Med; 2010 Oct; 4(5):557-66. PubMed ID: 20923335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19: Time to embrace MDI+ valved-holding chambers!
    Amirav I; Newhouse MT
    J Allergy Clin Immunol; 2020 Aug; 146(2):331. PubMed ID: 32482527
    [No Abstract]   [Full Text] [Related]  

  • 37. Refractory asthma coexisting with a double aortic arch: a case report and literature review.
    Yang HJ; Pyun BY
    J Asthma; 2010 Dec; 47(10):1165-7. PubMed ID: 20946085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicomorphological assessment of budesonide efficiency in patients with bronchial asthma].
    Budkova AA; Volkova LI; Budkov SR; Bogomiagkov VS
    Ter Arkh; 2003; 75(8):48-51. PubMed ID: 14520851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhaled nitric oxide.
    Stempel DA
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):381; author reply 381-2. PubMed ID: 15049405
    [No Abstract]   [Full Text] [Related]  

  • 40. Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy.
    Santus P; Giovannelli F; Di Marco F; Centanni S
    Expert Opin Pharmacother; 2010 Feb; 11(2):257-67. PubMed ID: 20088747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.